321 related articles for article (PubMed ID: 31624935)
1. A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging.
Kaissis G; Ziegelmayer S; Lohöfer F; Algül H; Eiber M; Weichert W; Schmid R; Friess H; Rummeny E; Ankerst D; Siveke J; Braren R
Eur Radiol Exp; 2019 Oct; 3(1):41. PubMed ID: 31624935
[TBL] [Abstract][Full Text] [Related]
2. A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy.
Kaissis G; Ziegelmayer S; Lohöfer F; Steiger K; Algül H; Muckenhuber A; Yen HY; Rummeny E; Friess H; Schmid R; Weichert W; Siveke JT; Braren R
PLoS One; 2019; 14(10):e0218642. PubMed ID: 31577805
[TBL] [Abstract][Full Text] [Related]
3. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma.
Park S; Sham JG; Kawamoto S; Blair AB; Rozich N; Fouladi DF; Shayesteh S; Hruban RH; He J; Wolfgang CL; Yuille AL; Fishman EK; Chu LC
AJR Am J Roentgenol; 2021 Nov; 217(5):1104-1112. PubMed ID: 34467768
[No Abstract] [Full Text] [Related]
4. Prediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumoral necrosis.
Noda Y; Tomita H; Ishihara T; Tsuboi Y; Kawai N; Kawaguchi M; Kaga T; Hyodo F; Hara A; Kambadakone AR; Matsuo M
BMC Med Imaging; 2022 Feb; 22(1):23. PubMed ID: 35135492
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MR imaging in pancreatic ductal adenocarcinoma: prediction of next-generation sequencing-based tumor cellularity and prognosis after surgical resection.
Jeon SK; Jang JY; Kwon W; Kim H; Han Y; Kim D; Park D; Kim JH
Abdom Radiol (NY); 2021 Oct; 46(10):4787-4799. PubMed ID: 34143259
[TBL] [Abstract][Full Text] [Related]
6. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract][Full Text] [Related]
8. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma.
Meng Y; Zhang H; Li Q; Xing P; Liu F; Cao K; Fang X; Li J; Yu J; Feng X; Ma C; Wang L; Jiang H; Lu J; Bian Y; Shao C
J Magn Reson Imaging; 2021 Nov; 54(5):1432-1443. PubMed ID: 33890347
[TBL] [Abstract][Full Text] [Related]
9. Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma.
Salinas-Miranda E; Healy GM; Grünwald B; Jain R; Deniffel D; O'Kane GM; Grant R; Wilson J; Knox J; Gallinger S; Fischer S; Khokha R; Haider MA
Eur Radiol; 2022 Oct; 32(10):6712-6722. PubMed ID: 36006427
[TBL] [Abstract][Full Text] [Related]
10. Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to differentiation of pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
Li J; Liang L; Yu H; Shen Y; Hu Y; Hu D; Tang H; Li Z
Magn Reson Imaging; 2019 Jan; 55():52-59. PubMed ID: 30240758
[TBL] [Abstract][Full Text] [Related]
11. Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma.
Kaissis GA; Ziegelmayer S; Lohöfer FK; Harder FN; Jungmann F; Sasse D; Muckenhuber A; Yen HY; Steiger K; Siveke J; Friess H; Schmid R; Weichert W; Makowski MR; Braren RF
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32155990
[TBL] [Abstract][Full Text] [Related]
12. Prediction of postoperative liver metastasis in pancreatic ductal adenocarcinoma based on multiparametric magnetic resonance radiomics combined with serological markers: a cohort study of machine learning.
Yuan Z; Shu Z; Peng J; Wang W; Hou J; Han L; Zheng G; Wei Y; Zhong J
Abdom Radiol (NY); 2024 Jan; 49(1):117-130. PubMed ID: 37819438
[TBL] [Abstract][Full Text] [Related]
13. Intravoxel incoherent motion DWI of the pancreatic adenocarcinomas: monoexponential and biexponential apparent diffusion parameters and histopathological correlations.
Ma C; Li Y; Wang L; Wang Y; Zhang Y; Wang H; Chen S; Lu J
Cancer Imaging; 2017 Apr; 17(1):12. PubMed ID: 28454564
[TBL] [Abstract][Full Text] [Related]
14. DWI of Pancreatic Ductal Adenocarcinoma: A Pilot Study to Estimate the Correlation With Metastatic Disease Potential and Overall Survival.
Garces-Descovich A; Morrison TC; Beker K; Jaramillo-Cardoso A; Moser AJ; Mortele KJ
AJR Am J Roentgenol; 2019 Feb; 212(2):323-331. PubMed ID: 30667305
[TBL] [Abstract][Full Text] [Related]
15. Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
Zeng P; Qu C; Liu J; Cui J; Liu X; Xiu D; Yuan H
Acta Radiol; 2023 Jul; 64(7):2221-2228. PubMed ID: 36474439
[TBL] [Abstract][Full Text] [Related]
16. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics.
He M; Liu Z; Lin Y; Wan J; Li J; Xu K; Wang Y; Jin Z; Tian J; Xue H
Eur J Radiol; 2019 Aug; 117():102-111. PubMed ID: 31307634
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Ductal Adenocarcinoma: Rim Enhancement at MR Imaging Predicts Prognosis after Curative Resection.
Lee S; Kim SH; Park HK; Jang KT; Hwang JA; Kim S
Radiology; 2018 Aug; 288(2):456-466. PubMed ID: 29664340
[TBL] [Abstract][Full Text] [Related]
19. Prediction of residual tumor and overall survival after first-line surgery in patients with pancreatic ductal adenocarcinoma using preoperative magnetic resonance imaging findings.
Bae JS; Kim JH; Kang HJ; Han JK
Acta Radiol; 2022 Apr; 63(4):435-446. PubMed ID: 33682455
[TBL] [Abstract][Full Text] [Related]
20. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
